Sentante

Kaunas, Lithuania

Sentante is a medical device company that develops robotic teleoperated systems for endovascular procedures.

$6.6M raised

Dec 2023

Seed

Top Investors

European Innovation CouncilPractica CapitalMedTech Innovator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sentante raised?

Sentante has raised $6.6M in total funding. The most recent round was Seed. The last funding was announced in December 2023.

Who are Sentante's investors?

Sentante's investors include European Innovation Council, Practica Capital, MedTech Innovator.

Where is Sentante headquartered?

Sentante is headquartered in Kaunas, Lithuania.

What does Sentante do?

Sentante is a medical device company that develops robotic teleoperated systems for endovascular procedures.

What stage is Sentante at?

Sentante is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 21, 2023.

MLA

"Sentante — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/sentante. Accessed June 4, 2026.

APA

VCBacked. (2023). Sentante — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/sentante

Wikipedia (cite web)

{{cite web |title=Sentante — Funding & Investors |url=https://www.vcbacked.co/company/sentante |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 21, 2023.